Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB | P10828 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | HRH1 | P35367 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.35 |
| ▸ | USP2 | O75604 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | HRH4 | Q9H3N8 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | HRH2 | P25021 | 1/20 | 0.31 |
| ▸ | KDM4A | O75164 | 5/20 | 0.31 |
| ▸ | KDM4C | Q9H3R0 | 5/20 | 0.31 |
| ▸ | KDM5A | P29375 | 1/20 | 0.31 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.31 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28581574 | 1.00 | THRB (0.43) | THRBALDH1A1TSHRMAPTHTR2A | |
| SCHEMBL24802216 | 1.00 | THRB (0.43) | THRBALDH1A1TSHRMAPTHTR2A | |
| SCHEMBL8885433 | 0.93 | ALDH1A1 (0.46) | THRBALDH1A1TSHRMAPTHTR2A | |
| SCHEMBL9175539 | 0.91 | ALDH1A1 (0.50) | THRBALDH1A1TSHRMAPTLMNA | |
| SCHEMBL9175598 | 0.91 | ALDH1A1 (0.50) | THRBALDH1A1TSHRMAPTLMNA | |
| SCHEMBL2454527 | 0.87 | ALDH1A1 (0.47) | ALDH1A1TSHRMAPTHTR2AHRH1 | |
| Hydrochloric Acid SCHEMBL28842899 | 0.87 | ALDH1A1 (0.46) | THRBALDH1A1TSHRMAPTDNM1 | |
| SCHEMBL9671940 | 0.84 | ALDH1A1 (0.45) | ALDH1A1TSHRMAPTHTR2AHRH1 | |
| SCHEMBL943310 | 0.84 | — | — | |
| SCHEMBL24450550 | 0.84 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116064598-B | Nucleic acid vaccine for coronavirus | 苏州艾博生物科技有限公司 | 2024-03-12 | — | — | CN | disclosed |
| CN-114907243-B | Ionizable lipid, composition and application thereof | 东南大学 | 2023-10-27 | — | — | CN | disclosed |
| CN-116836074-A | Ionizable lipid or pharmaceutically acceptable salt thereof, composition and application | 东南大学 | 2023-10-03 | — | — | CN | disclosed |
| CN-116615472-A | Polymer conjugated lipid compounds and lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2023-08-18 | — | — | CN | disclosed |
| CN-116332830-A | Lipid compounds and lipid nanoparticle compositions | 苏州艾博生物科技有限公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-116064598-A | Nucleic acid vaccine for coronavirus | 苏州艾博生物科技有限公司 | 2023-05-05 | — | — | CN | disclosed |
| CN-115724920-A | Nucleic acid vaccine for coronavirus and influenza virus | 中国人民解放军军事科学院军事医学研究院 | 2023-03-03 | — | — | CN | disclosed |
| CN-113874507-A | Nucleic acid vaccine for coronavirus | 苏州艾博生物科技有限公司 | 2021-12-31 | — | — | CN | disclosed |
| CN-113018449-B | Cationic lipid compounds, compositions containing the same and uses thereof | 苏州艾博生物科技有限公司 | 2021-09-07 | — | — | CN | disclosed |
| CN-112979483-B | Cationic lipid compound, composition containing same and application | 苏州艾博生物科技有限公司 | 2021-08-06 | — | — | CN | disclosed |
| CN-112979483-A | Cationic lipid compound, composition containing same and application | 苏州艾博生物科技有限公司 | 2021-06-18 | — | — | CN | disclosed |
| EP-3225621-A1 | IMPROVED AMINO LIPIDS AND METHODS FOR THE DELIVERY OF NUCLEIC ACIDS | Arbutus Biopharma Corporation (CA) | 2017-10-04 | — | — | EP | disclosed |
| EP-2743265-B1 | Improved amino lipids and methods for the delivery of nucleic acids | ARBUTUS BIOPHARMA CORP (CA) | 2017-03-15 | — | — | EP | disclosed |
| EP-1812381-B1 | ETHYLENICALLY UNSATURATED GROUP-CONTAINING ISOCYANATE COMPOUND AND PROCESS FOR PRODUCING THE SAME, AND REACTIVE MONOMER, REACTIVE (METH)ACRYLATE POLYMER AND ITS USE | SHOWA DENKO KK (JP) | 2011-02-16 | — | — | EP | disclosed |
| US-7579066-B2 | Ethylenically unsaturated group-containing isocyanate compound and process for producing the same, and reactive monomer, reactive (meth) acrylate polymer and its use | SHOWA DENKO K.K. (JP) | 2009-08-25 | — | — | US | disclosed |
| US-20080132597-A1 | Ethylenically Unsaturated Group-Containing Isocyanate Compound and Process for Producing the Same, and Reactive Monomer, Reactive (Meth) Acrylate Polymer and its Use | RESONAC CORPORATION (JP) | 2008-06-05 | — | — | US | disclosed |
| EP-1812381-A1 | ETHYLENICALLY UNSATURATED GROUP-CONTAINING ISOCYANATE COMPOUND AND PROCESS FOR PRODUCING THE SAME, AND REACTIVE MONOMER, REACTIVE (METH)ACRYLATE POLYMER AND ITS USE | SHOWA DENKO KABUSHIKI KAISHA (JP) | 2007-08-01 | — | — | EP | disclosed |
| WO-2006049264-A1 | ETHYLENICALLY UNSATURATED GROUP-CONTAINING ISOCYANATE COMPOUND AND PROCESS FOR PRODUCING THE SAME, AND REACTIVE MONOMER, REACTIVE (METH)ACRYLATE POLYMER AND ITS USE | SHOWA DENKO K.K. (JP) | 2006-05-11 | — | — | WO | disclosed |
| US-6004669-A | ELECTROSTATIC CHARGING MEMBER, UNIFORMLY DISPERSED IN A MODIFIED RESIN AS A BASE POLYMER BEING MODIFIED BY AN AMINE GROUP WHICH HAS AN ACID-BASE INTERACTION WITH THE OXIDATION-PROCESSED ELECTRICALLY-CONDUCTING AGENT, | FUJI XEROX CO., LTD. (JP) | 1999-12-21 | — | — | US | disclosed |
| US-5925893-A | POLYESTERURETHANE IONOMER | FUJI XEROX CO., LTD. (JP) | 1999-07-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132597-A1 | Ethylenically Unsaturated Group-Containing Isocyanate Compound and Process for Producing the Same, and Reactive Monomer, Reactive (Meth) Acrylate Polymer and its Use | ACAD9, ELOVL6, ELOVL5 | THRB 4474/4885ALDH1A1 119/4885TSHR 4731/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.